文献速递肝病消化道肿瘤与早癌

高乙肝核心相关抗原水平与中等病毒载量慢性HBV感染者肝细胞癌风险增加相关

High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
PubMed 文献 · Gastroenterology · 2019-08-27

研究纳入2666例HBsAg阳性、HBV基因B或C型、无肝硬化的成人,随访平均15.95年,未接受抗病毒治疗。基线HBcrAg水平是HCC发生的独立危险因素;在HBeAg阴性、HBV DNA 2000-19999 IU/mL且ALT正常的患者中,HBcrAg≥10 KU/mL者HCC风险显著增加(HR 6.29,95%CI 2.27-17.48)。

要点

  • 基线HBcrAg水平是慢性HBV感染者发生HCC的独立危险因素。
  • HBeAg阴性、HBV DNA 2000-19999 IU/mL且ALT正常者,HBcrAg≥10 KU/mL的HCC风险HR为6.29。
  • 中等病毒载量且HBcrAg低水平者HCC年发生率0.10%(95%CI 0.04%-0.24%)。

核心结论

  • 在2666例基因B或C型慢性HBV感染者的长期随访中,HBcrAg水平是HCC的独立危险因素。
  • HBcrAg水平≥10 KU/mL可识别中等病毒载量患者中HCC高风险人群。

研究设计与样本

  • 研究收集1985年至2000年台湾大学医院长期随访的2666例HBsAg阳性、基因B或C型、无肝硬化的成人数据。
  • 随访期间患者均未接受抗病毒治疗,基线HBV DNA、HBsAg和HBcrAg水平为回顾性检测,平均随访15.95年。

主要发现

  • 队列中209例发生HCC,发病率为4.91例/1000人年。
  • 基线HBcrAg水平与HCC发生呈正相关,多变量分析显示其为独立危险因素。
  • HBeAg阴性、HBV DNA 2000-19999 IU/mL且ALT正常者中,HBcrAg≥10 KU/mL者HCC风险HR为6.29(95%CI 2.27-17.48)。
  • 中等病毒载量且HBcrAg高水平者的HCC风险与高病毒载量(≥20000 IU/mL)者无显著差异。
  • 中等病毒载量且HBcrAg低水平者HCC年发生率为0.10%(95%CI 0.04%-0.24%)。

关键数值与推荐

  • HCC风险分析中,HBcrAg≥10 KU/mL作为识别中等病毒载量患者高风险状态的阈值。
  • 中等病毒载量定义为HBV DNA 2000-19999 IU/mL。
  • 高病毒载量定义为HBV DNA≥20000 IU/mL。

临床怎么用

  • 对于HBeAg阴性、HBV DNA 2000-19999 IU/mL且ALT正常的慢性HBV感染者,检测基线HBcrAg水平可能有助于识别HCC高风险个体。
  • HBcrAg≥10 KU/mL的中等病毒载量患者HCC风险与高病毒载量者无显著差异。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Chronic hepatitis B virus (HBV) infection is a risk factor for hepatocellular carcinoma (HCC). Serum levels of HB core-related antigen (HBcrAg) have been associated with active replication of HBV. We investigated whether HBcrAg levels are associated with development of HCC, especially in patients who do not require antiviral treatment. METHODS: We collected data from 2666 adults positive for hepatitis B surface antigen (HBsAg), infected with HBV genotypes B or C, and without liver cirrhosis, who had long-term follow-up at the National Taiwan University Hospital from 1985 through 2000. None of the patients received antiviral treatment during the follow-up. Baseline levels of HBV DNA, HBsAg, and HBcrAg were determined retrospectively and participants were followed for a mean of 15.95 years. The primary end point was an association between serum level of HBcrAg and HCC development. RESULTS: HCC developed in 209 patients in the cohort (incidence rate, 4.91 cases/1000 person-years). We found a positive association between baseline level of HBcrAg and HCC development; HBcrAg level was an independent risk factor in multivariable analysis. In the subgroup of hepatitis B e antigen-negative patients with HBV DNA levels from 2000 to 19,999 IU/mL (intermediate viral load [IVL]) and normal levels of alanine aminotransferase, HBcrAg levels of 10 KU/mL or more identified patients at increased risk of HCC (hazard ratio, 6.29; confidence interval, 2.27-17.48). Patients with an IVL and a high level of HBcrAg had a risk for HCC that did not differ significantly from that of patients with a high viral load (≥20,000 IU/mL). Patients with an IVL but a low level of HBcrAg had a low risk of HCC, with an annual incidence rate of 0.10% (95% confidence interval, 0.04%-0.24%). CONCLUSIONS: In a long-term follow-up study of 2666 patients with chronic HBV infection (genotypes B or C), level of HBcrAg is an independent risk factor of HCC. Moreover, HBcrAg level of 10 KU/mL identifies patients with an IVL who are at high risk for HCC.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Tseng TC, Liu CJ, Hsu CY, et al. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load. Gastroenterology. 2019. PMID: 31470004. doi:10.1053/j.gastro.2019.08.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。